← Leaderboards
Sergio Fazio
Vanderbilt University
$15,471,068
Attributed
$15,471,068
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2005–19$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$16,775,735 · 9
By mechanism
R01$13,450,624 · 4
P30$1,304,667 · 1
P01$1,275,195 · 1
U24$745,249 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Macrophage”
- Craig B Thompson · Sloan-Kettering Inst Can Research$41,669,179
- Howard Eliot Gendelman · Children'S Memorial Hospital (Chicago)$41,668,744
- Selwyn M Vickers · University Of Alabama At Birmingham$40,969,055
- Alan A Aderem · University Of Washington$38,969,733
- Alan Richard Tall · Columbia University Health Sciences$38,053,695
- John S Condeelis · Yeshiva University$33,855,255
Research focus
MacrophageCholesterolAtherosclerosisLipoproteinsMediatingApolipoprotein EPlasmaProteinsAtherogenesisCellsPathway InteractionsLow Density Lipoprotein ReceptorRegulationHigh Density LipoproteinsBaseIn VivoLipidsInflammationReceptor BindingAntiatherogenicArterial Fatty StreakLipoprotein ReceptorExcisionComplex
Grant awards (52)
Functional and structural correlates of PCSK9 association with lipoproteins$533,826
R01 · FY2019 · HL · contact PI
Functional and structural correlates of PCSK9 association with lipoproteins$533,826
R01 · FY2018 · HL · contact PI
Lipoprotein and HDL Function Core$256,505
P01 · FY2018 · HL · contact PI
Functional and structural correlates of PCSK9 association with lipoproteins$533,826
R01 · FY2017 · HL · contact PI
Lipoprotein and HDL Function Core$256,505
P01 · FY2017 · HL · contact PI
Functional and structural correlates of PCSK9 association with lipoproteins$530,746
R01 · FY2016 · HL · contact PI
Functional Hierarchy of Remnant Lipoprotein Receptors$396,550
R01 · FY2016 · HL · contact PI
Lipoprotein and HDL Function Core$256,505
P01 · FY2016 · HL · contact PI
Functional Hierarchy of Remnant Lipoprotein Receptors$390,604
R01 · FY2015 · HL · contact PI
Lipoprotein and HDL Function Core$251,062
P01 · FY2015 · HL · contact PI
Functional Hierarchy of Remnant Lipoprotein Receptors$100,000
R01 · FY2015 · HL · contact PI
Functional Hierarchy of Remnant Lipoprotein Receptors$256,332
R01 · FY2014 · HL · contact PI
Lipoprotein and HDL Function Core$254,618
P01 · FY2014 · HL · contact PI
PCSK9, Lipoprotein receptors, and Atherosclerosis$248,154
R01 · FY2014 · HL · contact PI
PCSK9, Lipoprotein receptors, and Atherosclerosis$243,992
R01 · FY2014 · HL · contact PI
Functional Hierarchy of Remnant Lipoprotein Receptors$137,334
R01 · FY2014 · HL · contact PI
PCSK9, Lipoprotein receptors, and Atherosclerosis$478,085
R01 · FY2013 · HL · contact PI
Functional Hierarchy of Remnant Lipoprotein Receptors$401,700
R01 · FY2013 · HL · contact PI
PCSK9, Lipoprotein receptors, and Atherosclerosis$502,190
R01 · FY2012 · HL · contact PI
PCSK9, Lipoprotein receptors, and Atherosclerosis$509,808
R01 · FY2011 · HL · contact PI
Functional Hierarchy of Remnant Lipoprotein Receptors$383,750
R01 · FY2011 · HL · contact PI
Analytical Resources Core$217,041
U24 · FY2011 · DK · contact PI
Functional Hierarchy of Remnant Lipoprotein Receptors$383,750
R01 · FY2010 · HL · contact PI
ANALYTICAL CORE$87,868
U24 · FY2010 · DK · contact PI
Functional Hierarchy of Remnant Lipoprotein Receptors$383,750
R01 · FY2009 · HL · contact PI
ANALYTICAL CORE$87,868
U24 · FY2009 · DK · contact PI
Functional Hierarchy of Remnant Lipoprotein Receptors$383,750
R01 · FY2008 · HL · contact PI
Macrophage Expression of APOAI and Atherosclerosis$362,679
R01 · FY2008 · HL · contact PI
ANALYTICAL CORE$174,460
U24 · FY2008 · DK · contact PI
Functional Hierarchy of Remnant Lipoprotein Receptors$10,745
R01 · FY2008 · HL · contact PI
Functional Hierarchy of Remnant Lipoprotein Receptors$398,569
R01 · FY2007 · HL · contact PI
Macrophage Expression of APOAI and Atherosclerosis$362,679
R01 · FY2007 · HL · contact PI
ANALYTICAL CORE$178,012
U24 · FY2007 · DK · contact PI
Macrophage Expression of APOAI and Atherosclerosis$373,511
R01 · FY2006 · HL · contact PI
Functional Hierarchy of Remnant Lipoprotein Receptors$368,629
R01 · FY2006 · HL · contact PI
Functional Hierarchy of Remnant Lipoprotein Receptors$23,796
R01 · FY2006 · HL · contact PI
DEVELOPMENT OF A CLINICAL NUTRITION RESEARCH UNIT$480,667
P30 · FY2005 · DK
Macrophage Expression of APOAI and Atherosclerosis$380,000
R01 · FY2005 · HL
Functional Hierarchy of Remnant Lipoprotein Receptors$377,500
R01 · FY2005 · HL
DEVELOPMENT OF A CLINICAL NUTRITION RESEARCH UNIT$824,000
P30 · FY2004 · DK
Functional Hierarchy of Remnant Lipoprotein Receptors$377,500
R01 · FY2004 · HL
MACROPHAGE EXPRESSION OF APOAI AND ATHEROSCLEROSIS$339,750
R01 · FY2004 · HL
Functional Hierarchy of Remnant Lipoprotein Receptors$377,500
R01 · FY2003 · HL
MACROPHAGE EXPRESSION OF APOAI AND ATHEROSCLEROSIS$339,750
R01 · FY2003 · HL
FUNCTIONAL HIERARCHY OF REMNANT LIPOPROTEIN RECEPTORS$350,895
R01 · FY2002 · HL
MACROPHAGE EXPRESSION OF APOAI AND ATHEROSCLEROSIS$340,313
R01 · FY2002 · HL
CORE--ANALYTICAL RESOURCES$0
U24 · FY2002 · DK
MACROPHAGE EXPRESSION OF APOAI AND ATHEROSCLEROSIS$340,875
R01 · FY2001 · HL
FUNCTIONAL HIERARCHY OF REMNANT LIPOPROTEIN RECEPTORS$340,675
R01 · FY2001 · HL
CORE--ANALYTICAL RESOURCES$0
U24 · FY2001 · DK
MACROPHAGE EXPRESSION OF APOAI AND ATHEROSCLEROSIS$338,970
R01 · FY2000 · HL
FUNCTIONAL HIERARCHY OF REMNANT LIPOPROTEIN RECEPTORS$314,315
R01 · FY2000 · HL